The Rise of Japan and China as Innovation Hubs

Provided By:

Health Advances

July 22, 2021

The development and commercialization of novel biopharmaceutical products in recent years has continued to offer more safe and efficacious treatment options for patients across therapeutic areas. While a good proportion of the world’s transformative drug development and early commercial resources for novel therapies are focused in the United States, the level of drug innovation in the rest of the world has begun to shift. In the past decade, Japan and China have invested in regulatory reform and established policies to increase drug innovation within their respective countries.

Post a Comment

You must be logged in to post a Comment.

FEEDBACK